Overview

Gender

female

Ms. Reumuth joined Kala in February of 2014 as Senior Director, Finance and Corporate Controller. She brings with her nearly 20 years of diversified finance and accounting experience. Ms. Reumuth was formerly Corporate Controller for Enobia Pharma (acquired by Alexion Pharmaceuticals). Prior to her tenure at Enobia, she spent several years at Genzyme Corporation in Cambridge, MA through the acquisition of ILEX Oncology in San Antonio, Texas.

Ms. Reumuth began her career as an auditor with the San Antonio office of Ernst & Young LLP. Ms. Reumuth earned her business degree from Texas A&M University – Corpus Christi and is a Certified Public Accountant.